Xenon Pharmaceuticals Inc (XENE)

Xenon Pharmaceuticals Inc (XENE) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $3.5B; returns 1 day -3.2%, 1 week +5.5%, 1 year -14.2%.

Xenon Pharmaceuticals Inc. is a neuroscience-focused biopharmaceutical company specializing in the discovery, clinical development, and potential commercialization of therapeutics for neurological and neuropsychiatric disorders.

Groups XENE belongs to

• Canada Companies
• Biotechnology
• Neuroscience
• Biopharmaceutical
• Clinical Stage Biotech
• Pharmaceuticals
• Neurological Disorders
• CNS Disorders
• Epilepsy
• Healthcare
• Clinical Stage

XENE financial model: income statement, cash flow and balance sheet